300942 易瑞生物
2024/09 - 九个月
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资102,996-29.06%145,179195,75821,9443,507
投资性房地产0--005,2505,387
固定资产50,660-11.28%57,10283,98652,62844,887
在建工程448,13625.66%356,626190,86751,3410
无形资产39,713-4.06%41,39342,40042,60044,124
商誉0--0000
其他非流动资产3,948-78.51%18,37095,02681,11328,852
645,4524.33%618,669608,036254,876126,757

流动资产
货币资金250,474-48.01%481,749247,451342,211379,097
应收账款83,0469.06%76,14883,87897,05262,300
存货38,72123.08%31,461100,60893,85961,590
其他流动资产361,064143.45%148,312242,482364,52223,143
733,305-0.59%737,670674,419897,644526,129

流动负债
短期借款0--0000
应付票据0--0000
应付帐款62,116-19.70%77,35265,10755,65814,644
其他流动负债79,58633.59%59,575134,676100,96863,475
141,7023.49%136,927199,784156,62678,119
流动资产净值591,603-1.52%600,743474,636741,018448,010
资产总额减流动负债1,237,0551.45%1,219,4121,082,672995,894574,767

非流动负债
长期借款111,34610.98%100,32956,32000
应付债券260,6056.17%245,452000
其他非流动负债11,388-54.27%24,90361,65149,31425,784
383,3403.41%370,684117,97149,31425,784

总权益
    实收股本400,8670.00%400,860400,860400,860360,000
    储备项目452,0240.87%448,134564,031543,903189,054
股东权益852,8910.46%848,994964,891944,763549,054
非控股权益825-410.15%(266)(190)1,817(70)